Home Cargo Therapeutics

Cargo Therapeutics

In operation
IPO
CAR-T Cell Therapy Developer
Basic
Enterprise Profile

Basic Information

Cargo Therapeutics is a biotechnology company dedicated to developing next-generation CAR-T cell therapies for cancer treatment. Cargo Therapeutics designs and develops cutting-edge, first-class CARs using proprietary platform technology, incorporating complex therapeutic payloads that have the potential to deliver durable responses effective for a broader range of cancer patients.
Cargo Therapeutics, Inc.
California,United States of America
15~50 people
January 01, 2021
info@cargo-tx.com

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Cell Technology
Concept
Tumor
Application Scenarios
Innovative Drugs